
Dr. James P. Allison
Regental Professor & Chair, Department of Immunology, Olga Keith Wiess Distinguished University Chair for Cancer Research, Director, Parker Institute for Cancer Research, Executive Director, Immunotherapy Platform, MD Anderson Cancer Center

Dr. Jedd D. Wolchok
Chief, Immuno-Oncology Service, Human Oncology and Pathogenesis Program Lloyd J. Old Chair, Clinical Investigation, Director, Parker Institute for Cancer Immunotherapy,Memorial Sloan Kettering, Associate Director, Ludwig Center for Cancer Immunotherapy, Professor of Medicine, Weill Medical College of Cornell University
USA

Dr. Rakesh K. Jain
A. W. Cook Professor of Radiation Oncology (Tumor Biology) Director, E.L. Steele Laboratories Department of Radiation Oncology Harvard Medical School and Massachusetts General Hospital Boston,USA

Dr. Solange Peters
Head of the Medical Oncology Department, Head of the Specialized Consultation for Thoracic Tumors, Physician in charge of the Center for thoracic tumors University of Lausanne,
Switzerland

Dr. John B. Haanen
Head of the Division of Medical Oncology and Staff Scientist, Division of Immunology, Professor of Translational Immunotherapy of Cancer, Leiden University Medical Centre,
The Netherlands

Dr. Olivira J. Finn
Chair and Professor, Department of Immunology, University of Pittsburgh School of Medicine, Director of the Immunology Program, University of Pittsburgh Cancer Institute,
USA

Dr. Padmanee Sharma
Professor,Department of Genitourinary Medical Oncology, Professor,Department of immune-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center,
USA

Dr. Sherene Loi,
MMBS (Hons), FRACP, PhD, FAHMS
Professor, Cancer Therapeutics
Head, Translational Breast Cancer Genomics and Therapeutics Lab
Peter MacCallum Cancer Centre
University of Melbourne,
Australia

Prof. Silvia Stacchiotti
Depart of Medical Oncology IRCCS Foundation,National Cancer Institute,
Milan,Italy

Dr. David Gottlieb
Professor of Haematology University of Sydney Program Director BMT, Head Cell Therapies, Westmead Hospital Sydney,
Sydney

Prof. Laura Locati
Head and Neck Unit Depart of Medical Oncology IRCCS Foundation, National Cancer Institute, Milan, Italy

Dr. Ravindran Kanesvaran
Deputy Head & Senior Consultant, Division of Medical Oncology, National Cancer Centre,
Singapore

Dr. Aung Naing
Associate Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center,
USA

Dr. Naval G. Daver
Associate Professor, Department of Leukemia, MD Anderson Cancer Center,
USA

Dr. Aditi Shastri
Assistant Professor of Oncology, Division of Hematologic Malignancies & Bone Marrow Transplant, Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, New York,
USA

Dr. Boro Dropulic
Chief Science Officer
Lentigen Technology, Inc.
USA

Nirali N. Shah
M.D., M.H.Sc.
Investigator,Pediatric Oncology Branch,
NIH Lasker Clinical Research Scholar,
NIH Distinguished Scholar
Head,
Hematologic Malignancies Section,
Center for Cancer Research
National Cancer Institute
USA